Drug biokinetic and toxicity assessments in rat and human primary hepatocytes and HepaRG cells within the EU-funded Predict-IV project.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Toxicology in Vitro

• Publication date

  2015-12-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.tiv.2015.04.014PMID 25952325
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations.

  2015cited by this paper
• Understanding the biokinetics of ibuprofen after single and repeated treatments in rat and human in vitro liver cell systems.

  2015cited by this paper
• Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing.

  2015cited by this paper
• Biokinetics of chlorpromazine in primary rat and human hepatocytes and human HepaRG cells after repeated exposure.

  2015cited by this paper
• Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period.

  2015cited by this paper
• In vitro kinetics of amiodarone and its major metabolite in two human liver cell models after acute and repeated treatments.

  2015cited by this paper
• Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells

  2014cited by this paper
• Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.

  2014cited by this paper
• Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells.

  2014cited by this paper
• Prediction of fraction metabolized via CYP3A in humans utilizing cryopreserved human hepatocytes from a set of 12 single donors

  2014cited by this paper
• Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature

  2013cited by this paper
• Transcriptomic Hepatotoxicity Signature of Chlorpromazine after Short- and Long-Term Exposure in Primary Human Sandwich Cultures

  2013cited by this paper
• Oxidative stress plays a major role in chlorpromazine‐induced cholestasis in human HepaRG cells

  2013cited by this paper
• Drug-Induced Inhibition of Mitochondrial Fatty Acid Oxidation and Steatosis

  2013cited by this paper
• Interindividual Variability in Gene Expression Profiles in Human Hepatocytes and Comparison with HepaRG Cells

  2012cited by this paper
• Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

  2012cited by this paper
• Cyclosporine A- and Tacrolimus-Mediated Inhibition of CYP3A4 and CYP3A5 In Vitro

  2012cited by this paper
• Plateable cryopreserved human hepatocytes for the assessment of cytochrome P450 inducibility: experimental condition-related variables affecting their response to inducers

  2012cited by this paper
• The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells.

  2011cited by this paper
• Induction of vesicular steatosis by amiodarone and tetracycline is associated with up‐regulation of lipogenic genes in heparg cells

  2011cited by this paper
• Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability

  2011cited by this paper
• Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in rat.

  2011cited by this paper
• Chlorpromazine quantification in human plasma by UPLC-electrospray ionization tandem mass spectrometry. Application to a comparative pharmacokinetic study.

  2011cited by this paper
• A robust high-throughput sandwich cell-based drug screening platform.

  2011cited by this paper
• Cell based approaches for evaluation of drug-induced liver injury.

  2010cited by this paper
• Inter-laboratory evaluation of the response of primary human hepatocyte cultures to model CYP inducers - a European Centre for Validation of Alternative Methods (ECVAM) - funded pre-validation study.

  2010cited by this paper
• Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile.

  2010cited by this paper
• Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II

  2010cited by this paper
• Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver--A comparison with other phenothiazines.

  2010cited by this paper
• Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I

  2010cited by this paper
• Glucuronidation and Covalent Protein Binding of Benoxaprofen and Flunoxaprofen in Sandwich-Cultured Rat and Human Hepatocytes

  2009cited by this paper
• Cytometric analysis for drug-induced steatosis in HepG2 cells.

  2009cited by this paper
• Ibuprofen-Induced Liver Injury in an Adolescent Athlete

  2009cited by this paper
• Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: a valuable model for in vitro toxicity and drug-drug interaction studies.

  2009cited by this paper
• Confirmation That Cytochrome P450 2C8 (CYP2C8) Plays a Minor Role in (S)-(+)- and (R)-(-)-Ibuprofen Hydroxylation in Vitro

  2008cited by this paper
• Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism

  2008cited by this paper
• In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous System

  2008cited by this paper
• Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism.

  2008cited by this paper
• Long-Term Functional Stability of Human HepaRG Hepatocytes and Use for Chronic Toxicity and Genotoxicity Studies

  2008cited by this paper
• Enantioselective formation of ibuprofen-S-acyl-glutathione in vitro in incubations of ibuprofen with rat hepatocytes.

  2008cited by this paper
• Applying mechanisms of chemical toxicity to predict drug safety.

  2007cited by this paper
• Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.

  2006cited by this paper
• Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein

  2006cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006cited by this paper
• EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS

  2006cited by this paper
• Hepatic cirrhosis caused by low-dose oral amiodarone therapy.

  2005cited by this paper
• Cholestatic liver injury due to ibuprofen.

  2005cited by this paper
• First dose of potential new medicines to humans: how animals help

  2004cited by this paper
• Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.

  2004cited by this paper
• Drug-induced liver injury.

  2004cited by this paper
• Pharmacokinetics of chlorpromazine and key metabolites

  2004cited by this paper
• Molecular aspects of bile formation and cholestasis.

  2003cited by this paper
• Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate Published, JLR Papers in Press, October 16, 2002. DOI 10.1194/jlr.M200200-JLR200

  2003cited by this paper
• Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology

  2002cited by this paper
• Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate.

  2002cited by this paper
• Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?

  2002cited by this paper
• Orthotopic liver transplantation after subacute liver failure induced by therapeutic doses of ibuprofen

  2002cited by this paper
• Infection of a human hepatoma cell line by hepatitis B virus

  2002cited by this paper
• Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases

  2001cited by this paper
• Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes.

  2000cited by this paper
• Subfulminant hepatitis requiring liver transplantation following ibuprofen overdose.

  2000cited by this paper
• A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor.

  2000cited by this paper
• Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6.

  1999cited by this paper
• Liver cell models in in vitro toxicology.

  1998cited by this paper
• Cationic Amphiphilic Drug-Induced Phospholipidosis

  1997cited by this paper
• Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents?

  1997cited by this paper
• Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C.

  1997cited by this paper
• Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone.

  1996cited by this paper
• Vanishing bile duct syndrome temporally associated with ibuprofen use.

  1996cited by this paper
• Cyclosporin A-mediated cholestasis in patients with chronic hepatitis after heart transplantation.

  1996cited by this paper
• Review of current clinical experience with prolonged (oral) etoposide in cancer treatment.

  1995cited by this paper
• Disposition and covalent binding of ibuprofen and its acyl glucuronide in the elderly

  1995cited by this paper
• Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.

  1993cited by this paper
• Histopathologic analysis of suspected amiodarone hepatotoxicity.

  1990cited by this paper
• Chronic liver disease after low daily doses of amiodarone. Report of three cases.

  1986cited by this paper
• Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.

  1984cited by this paper
• Effect of chlorpromazine on hepatic transport of indocyanine green in rats.

  1983cited by this paper
• Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine.

  1975cited by this paper

• In vitro test battery for testing molecular initiating events in chemical-induced cholestasis.

  2025cites this paper
• Comparative Analysis of Species-Specific Hepatocyte Function and Drug Effects in a Liver Microphysiological System PhysioMimix LC12 and 96-Well Plates.

  2025cites this paper
• The potential of organoids in toxicologic pathology: role of toxicologic pathologists in in vitro chemical hepatotoxicity assessment

  2022cites this paper
• Modélisation de la toxicité pré-médicamenteuse dans des cultures cellulaires et des organoïdes de foie

  2021cites this paper
• HiPSC-Derived Hepatocyte-like Cells Can Be Used as a Model for Transcriptomics-Based Study of Chemical Toxicity

  2021cites this paper
• The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds

  2020cites this paper
• Integrating biokinetics and in vitro studies to evaluate developmental neurotoxicity induced by chlorpyrifos in human iPSC-derived neural stem cells undergoing differentiation towards neuronal and glial cells

  2020cites this paper
• Mechanisms and in vitro models of drug-induced cholestasis

  2019cites this paper
• Prediction of Human Liver Toxicity Using In Vitro Assays: Limitations and Opportunities

  2018cites this paper
• Optimizing culture conditions for hepatic differentiation of human inducedpluripotent stem cells: from 3D culture systems to co-cultures

  2018cites this paper
• Hepatic differentiation of human iPSCs in different 3D models: A comparative study

  2017cites this paper
• Primary‐like human hepatocytes genetically engineered to obtain proliferation competence display hepatic differentiation characteristics in monolayer and organotypical spheroid cultures

  2016cites this paper
• Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans

  2016cites this paper
• Establishment of "in vitro" and "in vivo" models with underlying mitochondrial dysfunction for testing idiosyncratic drug toxicity

  2015cites this paper
• Biokinetics in repeated-dosing in vitro drug toxicity studies.

  2015cites this paper